PURINE & PYRIMIDINE ANALOGS
PURINE & PYRIMIDINE ANALOGS
- A subgroup of antimetabolite drugs.
I) PURINE ANALOGS:
- All purine analogs may cause immunosuppression on long-term use.
- Should be given cotrimoxazole for Pneumocystis prophylaxis.
- Drugs included:
- 6-mercaptopurine (6-MP), 6-thioguanine (6-TG), fludarabine phosphate & cladribine.
Important drug details:
1. 6-mercaptopurine (6-MP) & 6-thioguanine (6-TG):
- MOA:
- Purine antimetabolites activated by hypoxanthine-guanine phosphoribosyltransferase (HGPRTase) –> Resulting nucleotides –> Inhibiting several enzymes in purine biosynthesis & metabolism.
- 6-MP:
- Metabolized by xanthine oxidase.
- When administered along with allopurinol (xanthine oxidase inhibitor), 6-MP dose (also azathioprine) should be reduced to 1/4th of original dose.
- Uses:
- Mainly for leukemias treatment (both acute leukemias & CML).
- Adverse effects:
- Bone marrow suppression (dose-limiting toxicity).
- Hepatotoxicity.
2. Fludarabine phosphate:
- DOC for chronic lymphocytic leukemia (CLL).
- Severe pulmonary toxicity – Combination of pentostatin with Fludarabine.
3. Cladribine (adenine analogs):
- Resistant to degradation by adenosine deaminase.
- DOC for hairy cell leukemia treatment.
II) PYRIMIDINE ANALOGS:
- Drugs included:
- Cytarabine (cytosine arabinoside), 5-fluorouracil (5-FU), capecitabine, gemcitabine, 5-azacytidine & decitabine.
Important drug details:
1. Cytarabine:
- Single most effective agent for induction of remission in AML.
- MOA:
- Activated by kinases to form arabinoside CTP
- Arabinoside CTP – DNA polymerase inhibitor.
- Adverse effect:
- Neurotoxicity (ataxia & peripheral neuropathy) – High dose.
2. 5-FU:
- MOA:
- Converted to 5’-dUMP inhibiting TS.
- Causes single strand breaks thus affecting both DNA & RNA.
- 5-FU is catabolized by dihydropyrimidine dehydrogenase (DPD).
- Metabolism:
- Conversion to CO (major route of metabolism) & elimination by respiratory pathway.
- Leucovorin augments of 5-FU action.
3. Capecitabine:
- Oral pro-drug of 5-FU.
- Can cause hyperbilirubinemia.
- Adverse effects:
- Capecitabine & 5-FU: Causes hand and foot syndrome (a form of erythromelalgia manifested as tingling, numbness, pain, erythema, swelling and increased pigmentation).
4. Thiopurines (6MP & 6-TG): Metabolized by thiopurine methyltransferase 2 (TPMT).
5. Gemcitabine:
- Very potent radiosensitizer.
- DOC for pancreatic cancer.
6. 5‘-Azacytidine:
- MOA: Acts by DNA hypomethylation.
- Approved for myelodysplasia treatment.
Exam Important
- Purine & pyrimidine analogs are the subgroups of antimetabolite drugs.
- Drugs included in purine analogs are 6-mercaptopurine (6-MP), 6-thioguanine (6-TG), fludarabine phosphate & cladribine.
- 6-MP when administered along with allopurinol (xanthine oxidase inhibitor), 6-MP dose (also azathioprine) should be reduced to 1/4th of original dose.
- Fludarabine phosphate is DOC for chronic lymphocytic leukemia (CLL).
- Combination of pentostatin with Fludarabine causes severe pulmonary toxicity.
- Cladribine (adenine analogs) is DOC for hairy cell leukemia treatment.
- Drugs included in pyrimidine analogs are cytarabine (cytosine arabinoside), 5-fluorouracil (5-FU), capecitabine, gemcitabine, 5-azacytidine & decitabine.
- Cytarabine is a single most effective agent for induction of remission in AML.
- High dose of cytarabine causes neurotoxicity (ataxia & peripheral neuropathy).
- 5-FU is catabolized by dihydropyrimidine dehydrogenase (DPD).
- Capecitabine is an oral pro-drug of 5-FU.
- Capecitabine & 5-FU causes hand and foot syndrome.
- Thiopurines (6MP & 6-TG) are metabolized by thiopurine methyltransferase 2 (TPMT).
- Gemcitabine is DOC for pancreatic cancer.
- 5‘-Azacytidine acts by DNA hypomethylation which is approved for myelodysplasia treatment.
Don’t Forget to Solve all the previous Year Question asked on PURINE & PYRIMIDINE ANALOGS
Click Here to Start Quiz
Click Here to Start Quiz